Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9RFF

Crystal Structure of Human Rac1 Fused with the Scaffold Protein POSH (residues 319-371)

9RFF の概要
エントリーDOI10.2210/pdb9rff/pdb
関連するPDBエントリー9RFB
分子名称Ras-related C3 botulinum toxin substrate 1,E3 ubiquitin-protein ligase SH3RF1, PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER, MAGNESIUM ION, ... (5 entities in total)
機能のキーワードgtpase gtp/gdp-binding nucleotide binding, hydrolase
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数1
化学式量合計26234.11
構造登録者
Kjaer, L.F.,Ielasi, F.S.,Palencia, A.,Jensen, M.R. (登録日: 2025-06-04, 公開日: 2025-12-03, 最終更新日: 2026-01-07)
主引用文献Kjaer, L.F.,Ielasi, F.S.,Winbolt, T.,Delaforge, E.,Tengo, M.,Bessa, L.M.,Marino Perez, L.,Boeri Erba, E.,Bouvignies, G.,Palencia, A.,Jensen, M.R.
Hierarchical folding-upon-binding of an intrinsically disordered protein.
Nat Commun, 16:11346-11346, 2025
Cited by
PubMed Abstract: Intrinsically disordered proteins (IDPs) often undergo folding-upon-binding to their partners via short linear motifs, typically 5-15 amino acids in length. However, a significant proportion of IDPs do not adhere to this paradigm but fold upon binding through extended regions comprising multiple molecular recognition elements. For these IDPs, the binding mechanisms and the structural characteristics of their folding intermediates remain poorly understood. Here we unveil hierarchical folding of an IDP as it binds to its partner, exemplified by the disordered signaling effector POSH and the small GTPase Rac1. By combining nuclear magnetic resonance (NMR) spectroscopy and X-ray crystallography, we resolve at atomic resolution how POSH transitions from a fully disordered state to a highly ordered, Rac1-bound conformation through two structurally distinct folding intermediates. The folding of each element is contingent on the successful structuring of the preceding element, highlighting a hierarchical folding-upon-binding mechanism. Our work highlights the potential of targeting folding intermediates and conformational transitions to unlock therapeutic opportunities for IDPs.
PubMed: 41309611
DOI: 10.1038/s41467-025-66420-5
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.248 Å)
構造検証レポート
Validation report summary of 9rff
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon